{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:06Z","timestamp":1788401586075,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011045","name":"French Government Ministry of Higher Education Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"AP-HP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012948","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128130","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:22:59Z","timestamp":1767788579000},"page":"128130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1\/2 trial with dose finding study"],"prefix":"10.1016","volume":"74","author":[{"given":"Fanny","family":"Alby-Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Ouedrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Jateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Strullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Walter-Petrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaima","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Guilmatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ferreboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-France","family":"Ray-Lunven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Chatenoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morand-Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128130_bb0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jpeds.2004.12.043","article-title":"Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens","volume":"146","author":"Brodtman","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2025.128130_bb0010","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1182\/bloodadvances.2020003170","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH research Collaborative data hub","volume":"4","author":"Wood","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.vaccine.2025.128130_bb0015","doi-asserted-by":"crossref","first-page":"100775","DOI":"10.1016\/j.blre.2020.100775","article-title":"When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities","volume":"47","author":"Wang","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.vaccine.2025.128130_bb0020","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S1470-2045(21)00454-X","article-title":"Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study","volume":"22","author":"Mukkada","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2025.128130_bb0025","article-title":"Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic","volume":"7","author":"Bandyopadhyay","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2025.128130_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28392","article-title":"COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms?","volume":"67","author":"Andr\u00e9","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vaccine.2025.128130_bb0035","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.3390\/cancers12113398","article-title":"Impact of the first wave of COVID-19 on pediatric oncology and hematology: a report from the French Society of Pediatric Oncology","volume":"12","author":"Rouger-Gaudichon","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.vaccine.2025.128130_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28410","article-title":"Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy","volume":"67","author":"Ferrari","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vaccine.2025.128130_bb0045","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ccell.2021.06.009","article-title":"Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer","volume":"39","author":"Addeo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vaccine.2025.128130_bb0070","series-title":"Food and Drug Administration. Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials","year":"2007"},{"key":"10.1016\/j.vaccine.2025.128130_bb0075","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/sim.7295","article-title":"A design for phase I trials in completely or partially ordered groups","volume":"36","author":"Conaway","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0080","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1177\/0962280217703812","article-title":"Hierarchical models for sharing information across populations in phase I dose-escalation studies","volume":"27","author":"Cunanan","year":"2018","journal-title":"Stat Methods M\u00e9d Res"},{"key":"10.1016\/j.vaccine.2025.128130_bb0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41467-021-21111-9","article-title":"Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers","volume":"12","author":"Marot","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128130_bb0095","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/j.1600-6143.2009.02787.x","article-title":"Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients","volume":"9","author":"Candon","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2025.128130_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/sim.7087","article-title":"A Bayesian adaptive phase I\u2013II trial design for optimizing the schedule of therapeutic cancer vaccines","volume":"36","author":"Cunanan","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0105","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.21105\/joss.02376","article-title":"COVID-19 Data Hub","volume":"5","author":"Guidotti","year":"2020","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.vaccine.2025.128130_bb0110","article-title":"Immunogenicity and Reactogenicity of high- or standard-dose influenza vaccine in a second consecutive influenza season","author":"Bahakel","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128130_bb0115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJMc2210825","article-title":"Influenza vaccine in pediatric recipients of hematopoietic-cell transplants","volume":"388","author":"Schuster","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128130_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41408-022-00684-8","article-title":"Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review","volume":"12","author":"Piechotta","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.vaccine.2025.128130_bb0125","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/bloodadvances.2021006333","article-title":"Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis","volume":"6","author":"Teh","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.vaccine.2025.128130_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852158","article-title":"Seroconversion to mRNA SARS-CoV-2 vaccines in hematologic patients","volume":"13","author":"Fattizzo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128130_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccell.2021.11.006","article-title":"Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer","volume":"40","author":"Shapiro","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vaccine.2025.128130_bb0140","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:57:50Z","timestamp":1770253070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"alternative-id":["S0264410X25014288"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128130","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1\/2 trial with dose finding study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128130"}}